Lan Yuan-Tzu, Huang Kuo-Hung, Chen Ping-Hsien, Liu Chien-An, Lo Su-Shun, Wu Chew-Wun, Shyr Yi-Ming, Fang Wen-Liang
Division of Colon & Rectal Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.
National Yang-Ming University Hospital, Yilan City, Taiwan.
SAGE Open Med. 2017 Aug 21;5:2050312117727444. doi: 10.1177/2050312117727444. eCollection 2017.
Robotic gastrectomy has become increasingly popular in the treatment of gastric cancer, especially in Asian countries. The use of indocyanine green fluorescence has been reported in lymphatic mapping for gastric cancer in laparoscopic gastrectomy; however, there have been few reports regarding the use of indocyanine green in robotic gastrectomy.
From January 2011 to March 2016, a total of 79 patients underwent robotic gastrectomy for gastric cancer. Among them, intraoperative subserosal injection (n = 9) or preoperative submucosal injection (n = 5) of indocyanine green with near-infrared imaging was performed in 14 patients, and the other 65 patients underwent robotic gastrectomy without the use of indocyanine green.
There was no significant difference in the operative time, total number of retrieved lymph nodes, operative blood loss, and postoperative hospital stay between the patients who underwent robotic gastrectomy with or without indocyanine green fluorescence. For each lymph node station, there was significantly more number of retrieved lymph nodes in the indocyanine green group than in the no-indocyanine green group at the greater curvature side of the low body (#4d) to the infrapyloric region (#6) of the stomach. Five of the 14 patients who received an indocyanine green injection for lymphatic mapping had lymph node metastasis, and metastatic lymph nodes were located in the lymph node stations as detected by indocyanine green fluorescence during surgery.
Indocyanine green fluorescence with near-infrared imaging is feasible and is a promising method of lymphatic mapping in robotic gastrectomy for gastric cancer. In future studies, larger patient numbers and long-term follow-up are required.
机器人胃癌切除术在胃癌治疗中越来越受欢迎,尤其是在亚洲国家。腹腔镜胃癌切除术中吲哚菁绿荧光已被报道用于淋巴绘图;然而,关于吲哚菁绿在机器人胃癌切除术中的应用报道较少。
2011年1月至2016年3月,共有79例患者接受机器人胃癌切除术。其中,14例患者术中进行了吲哚菁绿浆膜下注射(n = 9)或术前黏膜下注射(n = 5)并结合近红外成像,另外65例患者未使用吲哚菁绿进行机器人胃癌切除术。
使用或未使用吲哚菁绿荧光进行机器人胃癌切除术的患者在手术时间、回收淋巴结总数、术中失血量和术后住院时间方面无显著差异。对于每个淋巴结站,在胃体下部大弯侧(#4d)至幽门下区域(#6),吲哚菁绿组回收的淋巴结数量明显多于未使用吲哚菁绿组。14例接受吲哚菁绿注射进行淋巴绘图的患者中有5例发生淋巴结转移,转移淋巴结位于手术中通过吲哚菁绿荧光检测到的淋巴结站。
吲哚菁绿荧光结合近红外成像在机器人胃癌切除术中进行淋巴绘图是可行的,且是一种有前景的方法。在未来的研究中,需要更大的患者数量和长期随访。